Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
DSCO > SEC Filings for DSCO > Form 8-K on 10-Jun-2013All Recent SEC Filings

Show all filings for DISCOVERY LABORATORIES INC /DE/ | Request a Trial to NEW EDGAR Online Pro

Form 8-K for DISCOVERY LABORATORIES INC /DE/


10-Jun-2013

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

On June 10, 2013, Discovery Laboratories, Inc. (the "Company"), announced that on June 7, 2013, it submitted its response to the U.S. Food and Drug Administration's (FDA) recent correspondence relating to the Company's recently updated product specifications for SURFAXIN®. The Company expects that the FDA may take up to four months to review the information provided. If its plan is successful and the FDA agrees with the response, the Company expects to proceed with the commercial introduction of SURFAXIN in the fourth quarter of 2013. A copy of the press release is attached hereto as Exhibit 99.1 and the text of such release is incorporated by reference herein.

The updated change in SURFAXIN product specifications is expected to have no impact on the Company's development programs, including AEROSURF®. The AEROSURF program currently remains on track for the initiation of phase 2 clinical program in the fourth quarter of 2013.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

99.1 Press release dated June 10, 2013

Cautionary Note Regarding Forward-looking Statements:

To the extent that statements in this Current Report on Form 8-K are not strictly historical, including statements as to business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of our product development, our plans regarding the anticipated commercial introduction of SURFAXIN and AEROSURF, the anticipated strategic alliance for the development and commercialization of SURFAXIN LS and AEROSURF or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this Current Report are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Such risks and others are further described in the Company's filings with the Securities and Exchange Commission including the most recent reports on Forms 10-K, 10-Q and 8-K, and any amendments thereto.


  Add DSCO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for DSCO - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.